BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 18816605)

  • 1. Epithelial and pseudoepithelial differentiation in glioblastoma and gliosarcoma: a comparative morphologic and molecular genetic study.
    Rodriguez FJ; Scheithauer BW; Giannini C; Bryant SC; Jenkins RB
    Cancer; 2008 Nov; 113(10):2779-89. PubMed ID: 18816605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric glioblastomas: a histopathological and molecular genetic study.
    Suri V; Das P; Pathak P; Jain A; Sharma MC; Borkar SA; Suri A; Gupta D; Sarkar C
    Neuro Oncol; 2009 Jun; 11(3):274-80. PubMed ID: 18981259
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comprehensive analysis of genomic alterations in gliosarcoma and its two tissue components.
    Actor B; Cobbers JM; Büschges R; Wolter M; Knobbe CB; Lichter P; Reifenberger G; Weber RG
    Genes Chromosomes Cancer; 2002 Aug; 34(4):416-27. PubMed ID: 12112531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and molecular characteristics of gliosarcoma and modern prognostic significance relative to conventional glioblastoma.
    Smith DR; Wu CC; Saadatmand HJ; Isaacson SR; Cheng SK; Sisti MB; Bruce JN; Sheth SA; Lassman AB; Iwamoto FM; Wang SH; Canoll P; McKhann GM; Wang TJC
    J Neurooncol; 2018 Apr; 137(2):303-311. PubMed ID: 29264835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: a clinical study in Chinese patients.
    Zhang G; Huang S; Zhang J; Wu Z; Lin S; Wang Y
    J Neurooncol; 2016 Apr; 127(2):355-62. PubMed ID: 26725096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidermal growth factor receptor (EGFR) gene amplification in high-grade gliomas: Western Indian tertiary cancer center experience.
    Shelly D; Epari S; Arora I; Pai T; Ahmed S; Moiyadi A; Chinnaswamy G; Gupta T; Goda J; Shetty P; Kane SV; Desai SB; Jalali R
    Neurol India; 2016; 64(1):115-20. PubMed ID: 26755002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic landscape of gliosarcoma: distinguishing features and targetable alterations.
    Zaki MM; Mashouf LA; Woodward E; Langat P; Gupta S; Dunn IF; Wen PY; Nahed BV; Bi WL
    Sci Rep; 2021 Sep; 11(1):18009. PubMed ID: 34504233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical outcome of gliosarcoma compared with glioblastoma multiforme: North Central Cancer Treatment Group results.
    Galanis E; Buckner JC; Dinapoli RP; Scheithauer BW; Jenkins RB; Wang CH; O'Fallon JR; Farr G
    J Neurosurg; 1998 Sep; 89(3):425-30. PubMed ID: 9724117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gliosarcoma arising in oligodendroglial tumors ("oligosarcoma"): a clinicopathologic study.
    Rodriguez FJ; Scheithauer BW; Jenkins R; Burger PC; Rudzinskiy P; Vlodavsky E; Schooley A; Landolfi J
    Am J Surg Pathol; 2007 Mar; 31(3):351-62. PubMed ID: 17325476
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic profile of gliosarcomas.
    Reis RM; Könü-Lebleblicioglu D; Lopes JM; Kleihues P; Ohgaki H
    Am J Pathol; 2000 Feb; 156(2):425-32. PubMed ID: 10666371
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gliosarcoma. A study of 13 tumors, including p53 and CD34 immunohistochemistry.
    Sreenan JJ; Prayson RA
    Arch Pathol Lab Med; 1997 Feb; 121(2):129-33. PubMed ID: 9126039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of CD70 (CD27L) Is Associated With Epithelioid and Sarcomatous Features in IDH-Wild-Type Glioblastoma.
    Pratt D; Pittaluga S; Palisoc M; Fetsch P; Xi L; Raffeld M; Gilbert MR; Quezado M
    J Neuropathol Exp Neurol; 2017 Aug; 76(8):697-708. PubMed ID: 28789475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CDKN2A deletion in pediatric versus adult glioblastomas and predictive value of p16 immunohistochemistry.
    Purkait S; Jha P; Sharma MC; Suri V; Sharma M; Kale SS; Sarkar C
    Neuropathology; 2013 Aug; 33(4):405-12. PubMed ID: 23311918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DJ-1 expression in glioblastomas shows positive correlation with p53 expression and negative correlation with epidermal growth factor receptor amplification.
    Hinkle DA; Mullett SJ; Gabris BE; Hamilton RL
    Neuropathology; 2011 Feb; 31(1):29-37. PubMed ID: 20497343
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Alterations in Gliosarcoma and Giant Cell Glioblastoma.
    Oh JE; Ohta T; Nonoguchi N; Satomi K; Capper D; Pierscianek D; Sure U; Vital A; Paulus W; Mittelbronn M; Antonelli M; Kleihues P; Giangaspero F; Ohgaki H
    Brain Pathol; 2016 Jul; 26(4):517-22. PubMed ID: 26443480
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glioblastomas with giant cell and sarcomatous features in patients with Turcot syndrome type 1: a clinicopathological study of 3 cases.
    Lusis EA; Travers S; Jost SC; Perry A
    Neurosurgery; 2010 Sep; 67(3):811-7; discussion 817. PubMed ID: 20657316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary glioblastomas with and without EGFR amplification: relationship to genetic alterations and clinicopathological features.
    Benito R; Gil-Benso R; Quilis V; Perez M; Gregori-Romero M; Roldan P; Gonzalez-Darder J; Cerdá-Nicolas M; Lopez-Gines C
    Neuropathology; 2010 Aug; 30(4):392-400. PubMed ID: 20051017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Amplification of the STOML3, FREM2, and LHFP genes is associated with mesenchymal differentiation in gliosarcoma.
    Nagaishi M; Kim YH; Mittelbronn M; Giangaspero F; Paulus W; Brokinkel B; Vital A; Tanaka Y; Nakazato Y; Legras-Lachuer C; Lachuer J; Ohgaki H
    Am J Pathol; 2012 May; 180(5):1816-23. PubMed ID: 22538188
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency and clinical significance of chromosome 7 and 10 aneuploidies, amplification of the EGFR gene, deletion of PTEN and TP53 genes, and 1p/19q deficiency in a sample of adult patients diagnosed with glioblastoma from Southern Brazil.
    Koshiyama DB; Trevisan P; Graziadio C; Rosa RFM; Cunegatto B; Scholl J; Provenzi VO; de Sá AP; Soares FP; Velho MC; de A P Filho N; Oliveira CA; Zen PRG
    J Neurooncol; 2017 Dec; 135(3):465-472. PubMed ID: 28856550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concurrent EGFR amplification and TP-53 mutation in glioblastomas.
    Gil-Benso R; Lopez-Gines C; Benito R; López-Guerrero JA; Callaghan RC; Pellín A; Roldán P; Cerdá-Nicolas M
    Clin Neuropathol; 2007; 26(5):224-31. PubMed ID: 17907599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.